Zeynep Nur Yurdakul
Research Subjects
Zeynep Nur Yurdakul has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hikmet Pehlevan Özel
Department of General Surgery, Ankara Bilkent City Hospital
2 shared publications - Sadettin Er
Department of General Surgery, Ankara Bilkent City Hospital
2 shared publications - Alparslan Ertenlice
Department of General Surgery, Ankara Bilkent City Hospital, Ankara, Türkiye; Department of General Surgery, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Türkiye
1 shared publication - Erdinç Çetinkaya
Department of General Surgery, Hacettepe University, Ankara, Turkey
1 shared publication - Gözde İğDeci Tut
Department of General Surgery, SBU Ankara Bilkent City Hospital, Ankara, Turkey
1 shared publication - Hüseyin Fahri Martlı
General Surgery Department Ankara Bilkent City Hospital Ankara Türkiye
1 shared publication
Latest Publications
- Open Access
- 23 June 2026
- Published by Springer Nature in Updates in Surgery
- p. 1-11
Early prediction of severe acute cholecystitis using routine admission parameters: a study of 1,330 patients
To evaluate routine clinical, demographic, and laboratory admission parameters as independent predictors of severe acute cholecystitis to facilitate early risk stratification. A total of 1,330 adult patients diagnosed with acute cholecystitis according to the Tokyo Guidelines 2018 (TG18) were analyzed in this single-center, retrospective study between 2019 and 2024. Patients were classified into mild/moderate (Group 1) and severe (Group 2) cohorts. Independent predictors of severe acute cholecystitis were determined using logistic regression and ROC analyses. To avoid incorporation bias, variables directly defining TG18 Grade 3 organ dysfunction were excluded from the multivariate models. Furthermore, internal validation was performed via bootstrap resampling (1000 iterations), and clinical utility was assessed using decision curve analysis (DCA). Group 2 (severe disease) comprised 12.9% (n = 172) of the cohort. The severe group was significantly older with a higher prevalence of diabetes. In multivariate analysis, the CRP/albumin ratio (CAR), age, diabetes mellitus, and hemoglobin level were identified as independent predictors The model demonstrated stable, moderate discriminatory power (AUC = 0.766). A Youden-derived CAR cut-off of > 1.10 significantly increased severe disease likelihood. DCA confirmed the model yielded superior net clinical benefit across relevant threshold probabilities. The combination of advanced age, diabetes mellitus, lower hemoglobin levels, and elevated CAR can provide a practical supportive framework for predicting severe acute cholecystitis. Within this multivariable approach, these routine admission parameters may enhance early bedside risk stratification and guide clinical vigilance alongside standard TG18 assessment.
- 23 June 2026
- Published by Springer Nature in Updates in Surgery
- p. 1-11
Open AccessEarly prediction of severe acute cholecystitis using routine admission parameters: a study of 1,330 patients
To evaluate routine clinical, demographic, and laboratory admission parameters as independent predictors of severe acute cholecystitis to facilitate early risk stratification. A total of 1,330 adult patients diagnosed with acute cholecystitis according to the Tokyo Guidelines 2018 (TG18) were analyzed in this single-center, retrospective study between 2019 and 2024. Patients were classified into mild/moderate (Group 1) and severe (Group 2) cohorts. Independent predictors of severe acute cholecystitis were determined using logistic regression and ROC analyses. To avoid incorporation bias, variables directly defining TG18 Grade 3 organ dysfunction were excluded from the multivariate models. Furthermore, internal validation was performed via bootstrap resampling (1000 iterations), and clinical utility was assessed using decision curve analysis (DCA). Group 2 (severe disease) comprised 12.9% (n = 172) of the cohort. The severe group was significantly older with a higher prevalence of diabetes. In multivariate analysis, the CRP/albumin ratio (CAR), age, diabetes mellitus, and hemoglobin level were identified as independent predictors The model demonstrated stable, moderate discriminatory power (AUC = 0.766). A Youden-derived CAR cut-off of > 1.10 significantly increased severe disease likelihood. DCA confirmed the model yielded superior net clinical benefit across relevant threshold probabilities. The combination of advanced age, diabetes mellitus, lower hemoglobin levels, and elevated CAR can provide a practical supportive framework for predicting severe acute cholecystitis. Within this multivariable approach, these routine admission parameters may enhance early bedside risk stratification and guide clinical vigilance alongside standard TG18 assessment.
- 28 November 2025
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (3) , 556-561
TROPIS Procedure in Complex Anal Fistulas: Single‐Center Long‐Term Results
Background: Transanal opening of the intersphincteric space (TROPIS) has recently emerged as a sphincter‐preserving option for the treatment of complex anal fistulas. Although high success rates have been reported in large international series, data on long‐term real‐world outcomes remain limited. This study aimed to evaluate long‐term results of TROPIS, focusing on recurrence and continence, and to compare them with existing literature. Methods: This retrospective single‐center cohort included 28 patients who underwent the TROPIS procedure between 2020 and 2023. Demographic data, Parks classification of fistula, operative details, recurrence rates, healing times, and continence outcomes were analyzed. Recurrence was defined as the reappearance of fistula after initial complete healing. Continence was assessed using the Wexner score. Patients were followed with a mean follow‐up of 680 ± 120 days. Results: The mean age was 42.6 years. According to Parks' classification, 21 patients (75%) had transsphincteric, 5 (17.9%) extrasphincteric, and 2 (7.1%) complex transsphincteric (horseshoe variant). The average healing time was 36 days. No recurrence occurred within the first 90 days; thereafter, 9 patients (32.1%) developed recurrence (median 225 days, range 90–660). Early postoperative mild incontinence occurred in 42.9% of patients, but only 5 (17.8%) reported persistent mild symptoms at long‐term follow‐up. No major incontinence was recorded. Conclusion: TROPIS appears to be a safe, sphincter‐preserving technique for complex anal fistulas, providing acceptable healing with preserved continence. However, recurrence rates in this cohort were higher than those reported internationally, underscoring the need for careful patient selection, surgical expertise, and adequate long‐term follow‐up.
- 28 November 2025
- Published by Wiley in Anz Journal of Surgery
- Vol. 96 (3) , 556-561
TROPIS Procedure in Complex Anal Fistulas: Single‐Center Long‐Term Results
Background: Transanal opening of the intersphincteric space (TROPIS) has recently emerged as a sphincter‐preserving option for the treatment of complex anal fistulas. Although high success rates have been reported in large international series, data on long‐term real‐world outcomes remain limited. This study aimed to evaluate long‐term results of TROPIS, focusing on recurrence and continence, and to compare them with existing literature. Methods: This retrospective single‐center cohort included 28 patients who underwent the TROPIS procedure between 2020 and 2023. Demographic data, Parks classification of fistula, operative details, recurrence rates, healing times, and continence outcomes were analyzed. Recurrence was defined as the reappearance of fistula after initial complete healing. Continence was assessed using the Wexner score. Patients were followed with a mean follow‐up of 680 ± 120 days. Results: The mean age was 42.6 years. According to Parks' classification, 21 patients (75%) had transsphincteric, 5 (17.9%) extrasphincteric, and 2 (7.1%) complex transsphincteric (horseshoe variant). The average healing time was 36 days. No recurrence occurred within the first 90 days; thereafter, 9 patients (32.1%) developed recurrence (median 225 days, range 90–660). Early postoperative mild incontinence occurred in 42.9% of patients, but only 5 (17.8%) reported persistent mild symptoms at long‐term follow‐up. No major incontinence was recorded. Conclusion: TROPIS appears to be a safe, sphincter‐preserving technique for complex anal fistulas, providing acceptable healing with preserved continence. However, recurrence rates in this cohort were higher than those reported internationally, underscoring the need for careful patient selection, surgical expertise, and adequate long‐term follow‐up.